CNIH2 - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CNIH2 - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CNIH2 - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | dog, guinea pig, human, mouse, rat, zebrafish |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against CNIH2. It was validated on Western BlotTarget Description: The protein encoded by this gene is an auxiliary subunit of the ionotropic glutamate receptor of the AMPA subtype. AMPA receptors mediate fast synaptic neurotransmission in the central nervous system. This protein has been reported to interact with the Type I AMPA receptor regulatory protein isoform gamma-8 to control assembly of hippocampal AMPA receptor complexes, thereby modulating receptor gating and pharmacology. Alternative splicing results in multiple transcript variants. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N-terminal region of Human CNIH2 |
| Other Names | [protein cornichon homolog 2; Protein cornichon homolog 2; protein cornichon homolog 2; cornichon family AMPA receptor auxiliary protein 2; Cornichon family AMPA receptor auxiliary protein 2; Cornichon-like protein] |
| Gene, Accession # | [CNIH2], Gene ID: 254263, NCBI: NP_872359, UniProt: Q6PI25 |
| Catalog # | MBS3217761 |
| Price | $335 |
| Order / More Info | CNIH2 - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies